HHS Secretary Kennedy adopts CDC advisors' chikungunya vaccine guidance for Bavarian Nordic's shot, while RSV vaccine ...

Calley Means, advisor to RFK Jr., challenges drugmakers considering pulling investment in the US over Trump's most favored ...

A Delaware jury on Thursday said Regeneron should get more than $400 million in damages in its long-running antitrust case ...

Bristol Myers Squibb CEO Chris Boerner said America’s role as the global biopharma leader is at a 'pivot point' as the Trump ...

The comments come just a couple months after the company slashed its 2027 sales expectations for the Biogen-partnered ...

Vinay Prasad may have just started as the new director of the FDA's biologics center, but he's 'planning to unleash a massive ...

Seventeen health systems have signed up for a venture firm to help them vet which health tech companies to adopt and invest ...

AGC Bio partners with Quell for vectors; Thermo Fisher makes Cybin's CYB003; PeptiSystems teams with Asahi Kasei; TriLink & ...

HHS Secretary Robert F. Kennedy Jr. faced hours of congressional grilling on Wednesday over his proposed budget cuts and ...

Plus, news about Allogene, Kyverna, Sernova, ADC Therapeutics, Acelyrin, Alumis, Atara, Lava Therapeutics and Repare ...

GSK to pay $1.2B upfront to Boston Pharmaceuticals for efimosfermin alfa, a MASH drug candidate. Deal includes $800M in ...

AbbVie partners with ADARx Pharmaceuticals in $335M upfront deal for siRNA tech collaboration across neuroscience, immunology ...